Evidence map›Paper›PMID 20646301›Full record

ArticleBMC bioinformatics2010

VIPR: A probabilistic algorithm for analysis of microbial detection microarrays.

Adam F Allred, Guang Wu, Tuya Wulan, Kael F Fischer, Michael R Holbrook, Robert B Tesh, David Wang

Abstract read
In one paragraph

Article in BMC bioinformatics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Viral pathogen discovery.Current opinion in microbiology · 2013
    Review
  2. Article
  3. Microarrays for pathogen detection and analysis.Briefings in functional genomics · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adam F AllredDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Guang Wu
Tuya Wulan
Kael F Fischer
Michael R Holbrook
Robert B Tesh
David Wang

Funding

A Diagnostic Microarray for hemorrhagic fever encephalitis virusesU01AI070374 · NIAID · WASHINGTON UNIVERSITY · PI WANG, DAVID · 2006 to 2010
$3.9M
NIAID NIH HHS U01 AI070374
6 · The paper itself

Abstract

backgroundAll infectious disease oriented clinical diagnostic assays in use today focus on detecting the presence of a single, well defined target agent or a set of agents. In recent years, microarray-based diagnostics have been developed that greatly facilitate the highly parallel detection of multiple microbes that may be present in a given clinical specimen. While several algorithms have been described for interpretation of diagnostic microarrays, none of the existing approaches is capable of incorporating training data generated from positive control samples to improve performance.

resultsTo specifically address this issue we have developed a novel interpretive algorithm, VIPR (Viral Identification using a PRobabilistic algorithm), which uses Bayesian inference to capitalize on empirical training data to optimize detection sensitivity. To illustrate this approach, we have focused on the detection of viruses that cause hemorrhagic fever (HF) using a custom HF-virus microarray. VIPR was used to analyze 110 empirical microarray hybridizations generated from 33 distinct virus species. An accuracy of 94% was achieved as measured by leave-one-out cross validation.

conclusionsVIPR outperformed previously described algorithms for this dataset. The VIPR algorithm has potential to be broadly applicable to clinical diagnostic settings, wherein positive controls are typically readily available for generation of training data.

Indexed as

AlgorithmsBayes TheoremHemorrhagic Fevers, ViralHumansOligonucleotide Array Sequence AnalysisRNA Viruses

Identifiers

PMID20646301
PMCPMC2921407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.